AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khong, P.-L.
Right arrow Articles by Ooi, G.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khong, P.-L.
Right arrow Articles by Ooi, G.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2003; 180:413-417
© American Roentgen Ray Society


MR Imaging of Spinal Tumors in Children with Neurofibromatosis 1

Pek-Lan Khong1, Winnie H. S. Goh2, Virginia C. N. Wong2, Cheuk-Wing Fung2 and Gaik-Cheng Ooi1

1 Department of Diagnostic Radiology, Rm. 406, Block K, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Rd., Hong Kong.
2 Department of Paediatrics, Queen Mary Hospital and Duchess of Kent Children's Hospital, The University of Hong Kong, Hong Kong.

Received June 17, 2002; accepted after revision July 29, 2002.

 
Address correspondence to P.-L. Khong.


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The need for radiologic surveillance of spinal tumors in children with neurofibromatosis 1 is controversial and unresolved. We aimed to determine the incidence of spinal tumors in asymptomatic patients, describe the imaging findings, and evaluate the clinical usefulness of a prospective MR imaging surveillance program of the spine in children with neurofibromatosis 1.

SUBJECTS AND METHODS. Of 62 children consecutively seen in a neurofibromatosis 1 clinic, 53 (85.5%) were recruited for MR imaging of the whole spine. All children satisfied the clinical criteria for diagnosis of neurofibromatosis 1. Imaging findings, clinical signs and symptoms, and subsequent clinical management were reviewed.

RESULTS. The patients were 35 boys and 18 girls (age range, 11 months—18 years; mean age, 9.6 years), all of whom were asymptomatic, with no remarkable neurologic signs. Seven children (13.2%) had spinal neurofibromas: four had solitary neurofibromas (two dumbbell, one intradural, and one paraspinal tumor) and three had plexiform neurofibromas of the sacral plexus and thoracic and lumbar nerve sheaths. The incidences of scoliosis, localized cutaneous neurofibromas, and massive soft-tissue neurofibromas were 71.4%, 71.4%, and 28.6%, respectively, in the group with spinal neurofibromas (n = 7), and 30.4%, 39.1%, and 8.7%, respectively, in the group without spinal neurofibromas (n = 46). Patient clinical outcome was affected in only one patient (1.9%) in whom a solitary neurofibroma was resected. Follow-up imaging in 10 patients (mean period, 29 months) showed no evidence of tumor occurrence, progression, or recurrence.

CONCLUSION. Although benign spinal neurofibromas are not uncommon in asymptomatic children with neurofibromatosis 1, the clinical usefulness of spine surveillance with MR imaging is limited in these children, making its effectiveness questionable.


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Neurofibromatosis 1, the most common neurocutaneous syndrome, is estimated to occur in approximately one of every 3300 infants [1]. Clinical diagnosis is made according to the diagnostic criteria established by the National Institutes of Health Consensus Development Conference in 1987 [2]. Manifestations are diverse and can arise from almost any system in the body. In the spine, lesions that can be detected on MR imaging are dysplasia of the dura, including lateral meningoceles and dural ectasia, and spinal tumors, most of which are benign neurofibromas. More rarely, malignant spinal tumors, including the malignant peripheral nerve sheath tumors and intramedullary tumors such as astrocytoma, occur [3,4,5,6]. On the basis of the high incidence (35.7%) of spinal tumors found on MR imaging in a study of both childhood and adult patients with neurofibromatosis 1, it has been suggested that MR screening of the whole spine should be performed for neurofibromatosis 1 [7]. Other authorities, on the other hand, do not advocate routine MR imaging but instead suggest that investigations should be dictated by clinical need [8]. In addition, data were lacking about the incidence of spinal tumors in children with neurofibromatosis 1 detected using MR imaging. The need for MR imaging surveillance of spinal tumors in children with neurofibromatosis 1 is therefore controversial and unresolved [9]. We conducted a prospective MR imaging surveillance program of the spine in children with neurofibromatosis 1 to determine the incidence of spinal tumors and the clinical significance of radiologic surveillance.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Between July 1995 and June 2001, 62 children were seen consecutively in the neurofibromatosis 1 clinic of a tertiary referral center that serves a population of 1.3 million on the island of Hong Kong. The children were referred by primary health care physicians, neonatologists, and other specialists such as neurologists and orthopedic surgeons. All children satisfied the clinical criteria for diagnosis of neurofibromatosis 1. Children registered in the clinic after January 1997 were prospectively imaged, whereas those registered before January 1997 were recalled for imaging. Informed consent was obtained from all patients or parents for MR imaging.

MR images of the whole spine were obtained using a Signa 1.5-T imager (General Electric Medical Systems, Milwaukee, WI) according to the following protocol: sagittal spin-echo T1-weighted, fast spin-echo proton density—weighted, and T2-weighted axial and coronal scans at selected locations followed by contrast-enhanced sagittal scans of the whole spine and contrast-enhanced axial or coronal scans at selected locations.

MR images were reviewed for the presence of spinal tumors, including the type (solitary discrete, multiple discrete, or plexiform), site (intramedullary, intradural, extradural, dumbbell, or paraspinal), location (cervical, thoracic, lumbar, or sacral), size, and MR imaging signal characteristics. Associated MR imaging findings, including the presence of dural ectasia, lateral meningoceles, and scoliosis, were recorded. MR imaging findings were correlated with clinical signs and symptoms, in particular, scoliosis, localized cutaneous neurofibromas (nodular or polypoid lesions of the skin), and massive soft-tissue neurofibromas (massive diffuse infiltrative lesions of the soft tissue or body part, often with hyperpigmentation of the overlying epidermis). Fisher's exact test was used to detect any significant differences in the incidence of scoliosis, localized cutaneous neurofibromas, and massive soft-tissue neurofibromas in the groups of children with and without spinal tumors on MR images. A p value of less than 0.05 was considered statistically significant.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Of a total of 62 children registered, 53 children (85.5%) (35 boys, 18 girls) between the ages of 11 months and 18 years (mean, 9.6 years) were enrolled in the program and underwent MR imaging.

MR Imaging Findings
Seven children (13.2%), all boys, with a mean age of 12.6 years (age range, 5-18 years) had spinal neurofibromas (Table 1). In four children, the neurofibromas were discrete, solitary, and right-sided, with a size range of 0.5-6.5 cm. Of these, two were dumbbell (Fig. 1), one was intradural, and one was paraspinal (Fig. 2A,2B). These were located in the sacral, lumbar, and upper thoracic nerves, respectively. Three children had plexiform neurofibromas; the lesions were widespread in two, involving the thoracic and lumbar nerve roots and the sacral plexus (Fig. 3A,3B,3C); and the remaining patient had a plexiform neurofibroma of the sacral plexus that was associated with a discrete solitary neurofibroma of the T12 nerve root. None had lesions in the cervical region. All lesions were isointense or hypointense on T1-weighted and hyperintense on T2-weighted images relative to the spinal cord, with hypointense centers on T2-weighted images (Fig. 2B) and enhancement after the administration of IV contrast material (Fig. 3A,3B,3C). No intramedullary tumors were recorded.


View this table:
[in this window]
[in a new window]

 
TABLE 1 MR Imaging Findings and Progress of Seven Children with Spinal Neurofibromas

 


View larger version (150K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1. Coronal spin-echo T1-weighted MR image of 11-year-old boy shows dumbbell neurofibroma of right L2 nerve root extending into intradural space and causing displacement of cauda equina (arrow). Tumor was subsequently resected, and pathology confirmed neurofibroma.

 


View larger version (171K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. 18-year-old man with upper thoracic paraspinal neurofibroma. Coronal spin-echo T1-weighted MR image shows paraspinal mass (arrow) in upper thoracic region that was associated with scoliosis.

 


View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. 18-year-old man with upper thoracic paraspinal neurofibroma. Axial fast spin-echo T2-weighted MR image with fat suppression shows same paraspinal tumor (arrow), which is markedly hyperintense but has hypointense center.

 


View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A. 14-year-old boy with plexiform neurofibroma of lumbar and sacral plexus. Coronal contrast-enhanced T1-weighted MR images of the lumbar (A, B) and sacral (C) spine show bilateral plexiform dumbbell neurofibromas that enhance with administration of contrast material.

 


View larger version (93K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B. 14-year-old boy with plexiform neurofibroma of lumbar and sacral plexus. Coronal contrast-enhanced T1-weighted MR images of the lumbar (A, B) and sacral (C) spine show bilateral plexiform dumbbell neurofibromas that enhance with administration of contrast material.

 


View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C. 14-year-old boy with plexiform neurofibroma of lumbar and sacral plexus. Coronal contrast-enhanced T1-weighted MR images of the lumbar (A, B) and sacral (C) spine show bilateral plexiform dumbbell neurofibromas that enhance with administration of contrast material.

 

Associated spinal findings in these seven patients were scoliosis (n = 5), dural ectasia (n = 3), and lateral meningoceles (n = 1). On clinical examination, all patients had café-au-lait spots. Other findings included localized cutaneous neurofibromas (n = 5), massive soft-tissue neurofibromas (n = 2), and deep intraneural neurofibromas (axilla, mediastinal, intercostal, and parapharyngeal regions, n = 1 each).

Clinical Signs and Symptoms
None of the children was symptomatic at presentation. Except for one child who had an absent knee reflex that did not correlate with the lesion, no children had neurologic signs referable to spinal or peripheral nerve disorders.

For children with spinal tumors, clinically detected scoliosis, localized cutaneous neurofibromas, and massive soft-tissue neurofibromas were found in 71.4%, 71.4%, and 28.6%, respectively; whereas the incidences of the same clinical findings in children without spinal tumors were 30.4%, 39.1%, and 8.7%, respectively. Using the Fisher's exact test, we were not able to detect any significant differences in the two groups of patients (p = 0.08, 0.22, and 0.17 respectively). The relative risks of having spinal neurofibromas in the presence of scoliosis, localized cutaneous neurofibromas, and massive soft-tissue neurofibromas were 2.4, 1.8, and 3.3, respectively.

Follow-Up
Two solitary lesions were resected: in one patient because of a tumor with a large intradural component, and in another patient because of thigh pain that developed during follow-up. Follow-up imaging was performed in 10 children over a mean period of 29 months. Six patients had spinal neurofibroma, and four patients had no lesions seen on the original scans. One patient with an upper thoracic paraspinal neurofibroma was not followed up with MR imaging after a Harrington rod was inserted for scoliosis. He remained asymptomatic at 7 years of clinical follow-up. No follow-up images showed evidence of new tumor occurrence, tumor progression, or recurrence.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
To our knowledge, ours is the only study to date that has systematically evaluated the incidence of spinal tumors in children with neurofibromatosis 1 whereby children consecutively enrolled in a widely based tertiary referral clinic were prospectively imaged by MR imaging. Ours is also the largest series describing the spinal manifestations of neurofibromatosis 1 on MR imaging in children. Before the advent of MR imaging, the incidence of spinal tumors in neurofibromatosis 1 was considered low: only 1.5% on a population-based cross-sectional study [10]. Only two other studies have evaluated the incidence of spinal tumors in patients with neurofibromatosis 1 using MR imaging, and those studies were performed in cohorts comprising both children and adults [7, 11]. Both studies found higher incidences of spinal tumors than we found in our study: Egelhoff et al. [7] reported an incidence of 39%, and Thakkar et al. [11] reported incidences of 96% and 40% for symptomatic and asymptomatic patients, respectively. The discrepancy between our study and those studies by Egelhoff et al. and Thakkar et al. may be due to differences in selection criteria and the process of case recruitment. The discrepancy may also imply that spinal tumors in patients with neurofibromatosis 1 develop with increasing age.

In addition to spinal neurofibromas, which formed most tumors, both Egelhoff et al. [7] and Thakkar et al. [11] also detected intramedullary tumors, which were not present in our cohort. These tumors were found to be astrocytomas on histopathology. The association of intramedullary tumors with neurofibromatosis 1, although rare, has been reported, in particular the association of astrocytomas ranging from low-grade to anaplastic astrocytomas and glioblastoma multiforme [12, 13].

None of our patients was symptomatic at presentation, in agreement with the study by Egelhoff et al. [7] in which all patients with extramedullary tumors were also asymptomatic. Thakkar et al. [11] found that most spinal tumors in children (younger than 15 years old) were asymptomatic, but the frequency of tumors that were symptomatic increased with age.

Three (42.9%) of seven children in our study had plexiform spinal neurofibromas involving multiple spinal levels. It is believed that most malignant peripheral nerve sheath tumors arise from plexiform neurofibromas, although the risk of malignant transformation is low, estimated to be about 2-6% [14,15,16]. The most common age at presentation of malignant peripheral nerve sheath tumor is during adulthood, at 20-50 years old [14, 15], which may explain why we did not detect any such tumor in our young cohort. Although most plexiform neurofibromas remain benign and grow slowly, it is the experience of some authors that their natural history is unpredictable, with some tumors exhibiting little growth over extended periods and others exhibiting episodic growth punctuated by extended periods of disease stability [17]. Presently, no known predictive factors determine which lesions are likely to behave aggressively or develop malignant changes [18]. MR imaging can aid in distinguishing malignant from benign nerve sheath tumors, with the following features suggestive of malignancy: enlarging tumor, large tumor size (>5 cm), ill-defined margins, lack of a central hypointense target on T2-weighted images, and heterogeneity with central necrosis [16, 19, 20]. MR imaging is therefore useful in the follow-up of these lesions, especially because these lesions cannot be evaluated clinically. Our study is limited by the relatively short follow-up period. Nonetheless, the lack of change in the spinal tumors suggests that the lesions are nonprogressive or slow-growing.

Some authors have observed that patients with plexiform neurofibromas or localized neurofibromas of large peripheral nerves frequently have clinical findings of scoliosis [21] and multiple cutaneous neurofibromas [14]. We found an increased incidence of these disorders in patients with spinal neurofibromas compared with those without, although the differences were not statistically significant. The lack of statistical significance can be attributed to the small sample size of our cohort. Larger studies are therefore needed to determine the usefulness of these clinical findings in predicting the presence of a spinal tumor and possibly in selecting cases for MR imaging surveillance.

In our series, clinical outcome was altered in only one patient (1.9%) on the basis of MR imaging surveillance. Another patient underwent resection of the spinal tumor after developing pain during follow-up. Although surgery is recommended for symptomatic solitary [18] and plexiform [17] neurofibromas, with good prognosis and minimal morbidity, treatment for asymptomatic tumors is mostly conservative [17]. In our institution, benign, asymptomatic tumors are resected only if they are enlarging or when a risk exists of spinal cord or cauda equina compression.

In conclusion, although we found that spinal neurofibromas are not uncommon in asymptomatic children with neurofibromatosis 1, the tumors are benign and do not warrant treatment. Malignant transformation is most likely to occur only in adulthood. The clinical usefulness of MR imaging surveillance of the spine in children with neurofibromatosis 1 is limited; therefore, the effectiveness of MR imaging of these patients on a large scale is questionable.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Cnossen MH, de Goede-Bolder A, van den Broek KM, et al. A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child 1998;78:408 -412[Abstract/Free Full Text]
  2. National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:575 -578[Abstract/Free Full Text]
  3. Faro SH, Higginson SN, Koenigsberg R, et al. Phakomatoses. I. Neurofibromatosis type 1: common and uncommon neuroimaging findings. J Neuroimaging 2000;10:138 -146[Medline]
  4. Shu BH, Mirowitz SA, Wippold FJ II. Neurofibromatosis: MR imaging findings involving the head and spine. AJR 1993;160:159 -164[Abstract/Free Full Text]
  5. Li MH, Holtas S. MR imaging of spinal neurofibromatosis. Acta Radiol 1991;32:279 -285[Medline]
  6. Burk DL, Brunberg JA, Kanal E, Latchaw RE, Wolf GL. Spinal and paraspinal neurofibromatosis: surface coil MR imaging at 1.5T. Radiology 1987;162:797 -801[Abstract/Free Full Text]
  7. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH. Spinal MR findings in neurofibromatosis type 1 and 2. AJNR 1992;3:1071 -1077
  8. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51 -57[Abstract/Free Full Text]
  9. Elster AD. Radiologic screening in the neurocutaneous syndromes: strategies and controversies. AJNR 1992;13:1078 -1082[Medline]
  10. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in South-East Wales. Brain 1988;111:1355 -1381[Abstract/Free Full Text]
  11. Thakkar SD, Feigen U, Mautner VF. Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology 1999;41:625 -629[Medline]
  12. Lee M, Rezai AR, Freed D, Epstein FJ. Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 1996;38:32 -37[Medline]
  13. Yagi T, Ohata K, Haque M, Hakuba A. Intramedullary spinal cord tumor associated with neurofibromatosis type 1. Acta Neurochir (Wien) 1997;139:1055 -1060
  14. Woodruff JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 1999;89:23 -30[Medline]
  15. Hajdu SI. Peripheral nerve sheath tumors. Cancer 1993;72:3549 -3552[Medline]
  16. Lin J, Martel W. Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography. AJR 2001;176:75 -82[Free Full Text]
  17. Pollack IF, Colak A, Fitz C, Wiener E, Moreland M, Mulvihill JJ. Surgical management of spinal cord compression from plexiform neurofibromas in patients with neurofibromatosis 1. Neurosurgery 1998;43:248 -255[Medline]
  18. Klekamp J, Samii M. Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis. Neurosurgery 1998;42:279 -290[Medline]
  19. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 1997;27:124 -129[Medline]
  20. Levine E, Huntrakoon M, Wetzel LH. Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR 1987;149:1059 -1064[Abstract/Free Full Text]
  21. Schorry EK, Crawford AH, Egelhoff JC, Lovell AM, Saal HM. Thoracic tumors in children with neurofibromatosis-1. Am J Med Genet 1997;74:533 -537[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
G. P. Gebauer, P. Farjoodi, D. M. Sciubba, Z. L. Gokaslan, L. H. Riley III, B. A. Wasserman, and A. J. Khanna
Magnetic Resonance Imaging of Spine Tumors: Classification, Differential Diagnosis, and Spectrum of Disease
J. Bone Joint Surg. Am., November 1, 2008; 90(Supplement_4): 146 - 162.
[Full Text] [PDF]


Home page
ImagingHome page
A Alam and J Teh
MRI assessment of scoliosis
Imaging, December 1, 2005; 17(3): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. R. Korf, J. W. Henson, and A. Stemmer-Rachamimov
Case 13-2005 - A 48-Year-Old Man with Weakness of the Limbs and Multiple Tumors of Spinal Nerves
N. Engl. J. Med., April 28, 2005; 352(17): 1800 - 1808.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khong, P.-L.
Right arrow Articles by Ooi, G.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khong, P.-L.
Right arrow Articles by Ooi, G.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS